Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3190841 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
Inaccurate and inconsistent information about EC safety and efficacy, tobacco harm reduction, and nicotine toxicity is being offered to smokers and EC users. In particular, most health care professionals cannot communicate a clear and consistent message to their patients with respiratory problems and allergy who use or intend to use ECs. Therefore, it is important for the medical community to take an active role in considering all the pathways available to a smoking patient and recommend those that provide the greatest probability of eliminating exposure to tobacco smoke, including ECs.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Riccardo MD, PhD, Davide MD, Mark F. MD,